1

'Company strategy won't change'

is the largest deal in the Indian pharmaceutical space, Japan's Daiichi Sankyo announced that it would buy a controlling stake in India's Ranbaxy Laboratories for up to $4.6 billion. Read »
Created by deep Created 17 weeks 5 days ago – Made popular 17 weeks 5 days ago
Category: Business

Similar stories

Ranbaxy promoters to sell stake to Daiichi Created 17 weeks 5 days ago
Malvinder insists multinational plotted to derail Daiichi deal Created 12 weeks 3 days ago
Generics space may see more of Daiichi-Ranbaxy type deals Created 3 weeks 4 days ago
Ranbaxy-Daiichi deal a windfall for little-known firm Created 5 weeks 4 days ago
Ranbaxy board approves takeover by Daiichi Created 12 weeks 6 days ago
Experts call Ranbaxy sell off as good deal Created 17 weeks 4 days ago
Daiichi says terms of open offer for Ranbaxy may change Created 10 weeks 2 days ago

User login

Syndicate

Syndicate content